Strategies for Implementing Lung Cancer Screening Programs in Low-Middle Income Countries

Low-Dose CT Could be One-Stop Test for Early Signs of China’s ‘Big Three’ Chest Diseases

The 50-year Journey to Optimize Lung Cancer Screening Programs

Optimizing CT Performance Through Use of Tumor Phantoms

IASLC Studying Impact of COVID-19 on International Lung Cancer Clinical Trial Enrollment, Mitigation Strategies

Prolonging CT Screening Intervals is Deemed Safe in Individuals with Negative Baseline Results

A National Network Provides a Window into Lung Cancer Screening Trends, Successes across the United States

Olaparib Maintenance Did Not Improve PFS, OS in Platinum-Sensitive NSCLC

CheckMate 9LA Combination Effective in Advanced NSCLC Despite PD-L1 Expression, TMB Status

PACIFIC-R: Findings Reflect Clinical Reality of Consolidation Therapy in Stage III NSCLC

Symposium Chairs Reflect on Current Status, Next Steps for Lung Cancer Screening on a Global Scale

The “Holy Grail” of Lung Cancer Research: Bring the Immune System into Every Tumor